These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20077524)

  • 1. Toxicity of nanomaterials to the eye.
    Prow TW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):317-33. PubMed ID: 20077524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological properties of engineered nanomaterials.
    Dobrovolskaia MA; McNeil SE
    Nat Nanotechnol; 2007 Aug; 2(8):469-78. PubMed ID: 18654343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters.
    Tong YC; Chang SF; Liu CY; Kao WW; Huang CH; Liaw J
    J Gene Med; 2007 Nov; 9(11):956-66. PubMed ID: 17724775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine and nanotoxicology: two sides of the same coin.
    Kagan VE; Bayir H; Shvedova AA
    Nanomedicine; 2005 Dec; 1(4):313-6. PubMed ID: 17292104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety assessment of nanomaterials: implications for nanomedicine.
    Nyström AM; Fadeel B
    J Control Release; 2012 Jul; 161(2):403-8. PubMed ID: 22306428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology of nanomaterials used in nanomedicine.
    Zhao J; Castranova V
    J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of nanoparticles in ophthalmology.
    Diebold Y; Calonge M
    Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of nanomedicine for ocular drug delivery.
    Meng T; Kulkarni V; Simmers R; Brar V; Xu Q
    Drug Discov Today; 2019 Aug; 24(8):1524-1538. PubMed ID: 31102733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.